Flow Pharma, Inc.
PrivateLast Round
Grant
May 13, 2020
Total Funding Raised
$1.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Flow Pharma, Inc. operates in Healthcare & Life Sciences and is based in Warrensville Heights, Ohio. Its latest recorded funding round was a Grant round in May 2020.
Flow Pharma, Inc. is a biotechnology company that develops T-cell based vaccine delivery platforms and immunotherapies for the treatment and prevention of cancer and viral diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flow Pharma, Inc. Comparables
Compare Flow Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gritstone bio | 79% | |
| PDS Biotechnology Corp | 77% | |
| PathoVax LLC | 73% |
For institutional investors. Book with your work email.
Flow Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2020 | ||||
| Seed | Sep 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Flow Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Button Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 31% MoM, reaching 2.2K.
- Jul 28, 2026
Monthly visitors increased 140% MoM.
For institutional investors. Book with your work email.
Flow Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flow Pharma, Inc.'s valuation, stock price, and market status.
Is Flow Pharma, Inc. a public or private company?
Flow Pharma, Inc. is a private company.
What is the current stock price of Flow Pharma, Inc.?
Flow Pharma, Inc. is a private company, so its shares have no public market price. Caplight tracks Flow Pharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flow Pharma, Inc. worth (valuation)?
Valuation information for Flow Pharma, Inc. is not publicly available.
Can I buy Flow Pharma, Inc. stock?
Flow Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flow Pharma, Inc.'s last funding round?
Flow Pharma, Inc.'s most recent funding round was Grant on May 13, 2020.
Who are the main investors in Flow Pharma, Inc.?
Key investors in Flow Pharma, Inc. include United States Department of Defense, Button Capital.
Will Flow Pharma, Inc. IPO soon?
No public IPO plans have been announced for Flow Pharma, Inc..
How can I track Flow Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Flow Pharma, Inc.'s shares on secondary markets.